Pulmonary Vascular Disease News

A new study highlights a reduction in idiopathic pulmonary artery hypertension-related hospitalizations in the U.S. from 2007 to 2017.

In the phase 2 ARROW trial, selonsertib for 24 weeks failed to significantly reduce pulmonary vascular resistance or achieve clinical improvement in patients with pulmonary arterial hypertension.

Pharmacomechanical catheter-directed thrombolysis using an endovascular catheter was safe and effective in patients with pulmonary embolism, according to interim results of the RESCUE trial presented at VIVA 21.

This week, use of systemic corticosteroids is linked with worse COVID-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more.

Patients with pulmonary hypertension in COPD had worse clinical status and poorer outcomes compared with those with idiopathic pulmonary artery hypertension, according to findings published in Chest.

Because sudden cardiac death can occur in patients with CVD traveling to higher altitudes, experts recommended in a new American Heart Association scientific statement that patients with CVD consult a physician before travel.

A new study identified high mortality rates for children with pulmonary hypertension who were admitted to pediatric cardiac ICUs during a 5-year period.

This week, symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection; US to offer booster shots to fully vaccinated Americans starting Sept. 20; CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers; and more.

This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.

Patients with pulmonary hypertension who undergo primary or revision total knee arthroplasty have increased mortality and complications within 90 days of surgery, according to published results.